Oortwijn, Wija <br/><br/>
The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries.  [electronic resource] 

 -  Health policy (Amsterdam, Netherlands)  May 2010 
 - 174-84 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-6054 
<br/><br/><label>Standard No.: </label>10.1016/j.healthpol.2009.12.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Argentina<br/>Brazil<br/>China<br/>Colombia<br/>Decision Making, Organizational<br/>Developing Countries<br/>Drug and Narcotic Control--organization & administration<br/>Government Regulation<br/>Health Services Research<br/>Humans<br/>Insurance Coverage--organization & administration<br/>Insurance, Pharmaceutical Services--economics<br/>Israel<br/>Marketing of Health Services<br/>Mexico<br/>National Health Programs--organization & administration<br/>Philippines<br/>Reimbursement Mechanisms--organization & administration<br/>Republic of Korea<br/>Taiwan<br/>Technology Assessment, Biomedical--organization & administration<br/>Thailand<br/>Turkey